Immunohistochemistry Digital Breast Cancer Panel 1 Test
Comprehensive Breast Cancer Biomarker Analysis
The Immunohistochemistry Digital Breast Cancer Panel 1 Test represents a cutting-edge approach to breast cancer diagnosis and treatment planning. This advanced diagnostic tool utilizes sophisticated immunohistochemistry techniques combined with digital pathology to provide precise analysis of crucial biomarkers that determine treatment responsiveness and prognosis.
What This Test Measures and Detects
This comprehensive panel evaluates several critical biomarkers essential for breast cancer management:
- Estrogen Receptor (ER) Status: Determines if cancer cells have estrogen receptors, indicating potential responsiveness to hormone therapy
- Progesterone Receptor (PR) Status: Assesses progesterone receptor presence, providing additional information about hormone responsiveness
- Malignant Cell Confirmation: Includes expert pathologist review to verify the presence of malignant cells in the tissue sample
- Photomicrograph Documentation: Provides high-quality digital images of the tissue sample for comprehensive analysis
Who Should Consider This Test
This test is particularly important for individuals experiencing or diagnosed with:
- Newly diagnosed breast cancer requiring biomarker analysis
- Recurrent breast cancer needing updated biomarker status
- Patients with suspicious breast lumps or abnormal mammogram findings
- Individuals requiring treatment planning for hormone receptor-positive breast cancer
- Patients considering targeted therapy options
- Those needing confirmation of malignant cell presence in biopsy samples
Key Benefits of the Immunohistochemistry Digital Breast Cancer Panel 1 Test
- Personalized Treatment Planning: Results guide targeted therapy decisions based on hormone receptor status
- Advanced Digital Technology: Utilizes cutting-edge digital pathology for enhanced accuracy
- Comprehensive Analysis: Provides multiple biomarker assessments in a single test
- Expert Pathologist Review: Includes professional evaluation to ensure accurate results
- Treatment Response Prediction: Helps predict how breast cancer may respond to hormone therapies
- Prognostic Information: Provides valuable insights into disease progression and outcomes
Understanding Your Test Results
Your test results will provide detailed information about:
- ER Status: Positive results indicate potential responsiveness to estrogen-blocking therapies
- PR Status: Positive results suggest additional hormone therapy options may be effective
- Malignant Cell Confirmation: Verifies the presence of cancer cells in the analyzed tissue
- Digital Documentation: High-resolution images for reference and consultation
Your healthcare provider will interpret these results in the context of your overall health status and develop a personalized treatment plan based on the findings.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry Digital Breast Cancer Panel 1 Test | $126 USD | $188 USD |
Nationwide Availability
We have branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our extensive network ensures convenient access to this essential breast cancer diagnostic testing.
Book Your Test Today
Take control of your breast cancer diagnosis and treatment planning with our comprehensive Immunohistochemistry Digital Breast Cancer Panel 1 Test. Our advanced digital pathology technology and expert pathologist review provide the detailed biomarker information needed for personalized treatment decisions.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or to speak with our healthcare specialists about this important diagnostic procedure.
With our discounted price of only $126 USD (regularly $188 USD), you can access state-of-the-art breast cancer biomarker analysis that can significantly impact your treatment journey and outcomes.
